logo
episode-header-image
Mar 2022
28m 22s

Episode 008: Metastatic Cancer of “Origi...

Rouleaux University Medical Center
About this episode

Not to be confused with “carcinoma of unknown primary,” in this episode of metastatic disease of “origin TBD”, we discuss the workup of a mass noted incidentally on imaging. This is a very high yield topic often faced on solid oncology consults!

Major Points Covered:

Mass found incidentally on imaging → we need to stage always

Initial Workup:

Reasonable to get CBC, CMP, UA, PSA (if male)

Low blood counts, maybe marrow involvement

Cr elevated concern for obstruction possibly

LFTs elevated concern for mass in the biliary/pancreas region

UA w/ hematuria → maybe bladder

But bottom line you’re gonna get a scan, which scan to get though?

Recommend referencing NCCN guidelines to determine additional staging scans

Create an account on nccn.org and look at guidelines by tumor type

Not all cancers require a PET/CT scan

There are newer modalities for imaging other than FDG PET including PSMA PET (prostate), Auxumin PET (prostate), and DOTATE PET (neuroendocrine)

Certain cancers can be diagnosed on imaging alone (RCC and HCC)

Some cancers require Brain MRI for staging

What to biopsy?

FNA often adequate for solid tumors but may need core if non diagnostic

Need core or ideally excisional if highly concerned for lymphoma

Always try to biopsy the site that will upstage

Distant lymph nodes or other metastatic sites

What about tumor markers?

We use this for treatment monitoring, not for diagnostic purposes

Important to establish a baseline to follow, special circumstances for diagnostic purposes to consider below:

PSA in male if concerned about prostate cancer

AFP helpful if concerned for HCC → liver masses in a cirrhotic

AFP and b-HCG if concerned for testicular → young or middle aged male with mediastinal mass

Molecular testing not necessarily needed at the time of biopsy 

Please visit our website (TheFellowOnCall.com) for more information

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Up next
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we highly recommend listening to part 3 of our follicular lymphoma series. You may al ... Show More
36m 11s
Sep 10
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)
This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 ... Show More
29m 51s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. Episode contents:- What is the front-line approach to management for locali ... Show More
30m 11s
Recommended Episodes
Feb 2024
EKU Podcast: Faecal immunochemical testing
Colorectal cancer is the fourth most common type of cancer in the UK, with over 40,000 new cases each year. The positive predictive value of Faecal immunochemical testing (FIT) far exceeds that of symptoms and makes FIT an important tool for triaging patients with symptoms sugges ... Show More
21m 21s
Sep 4
Colorectal Cancer
Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice.We start by brea ... Show More
37m 25s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Mar 2025
Lymphoma
Ninja Nerds,Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Lymphoma, breaking down its pathogenesis, clinical presentation, and the latest advancements in treatment. We explore the key differences between Hodgkin and Non-Hodgkin Lymphoma, ... Show More
34m 14s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and the ... Show More
24m 31s
Mar 2023
S4 E9: "Do The Maths" song; JOMT interview - Dr Sam Merriel talks about prostate cancer; also antibiotic resistance, nitrofurantoin failure, kidney stones
Welcome to the Hot Topics Podcast with host, Dr Neal Tucker. In this bumper edition we have the next in our Just One More Thing series. We interview Dr Sam Merriel in collaboration with Prostate Cancer UK, talking about what we need to know in the world of prostate cancer. Should ... Show More
40m 32s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal improvem ... Show More
24m 4s
Sep 25
Urinary Tract Malignancies
Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob dive into the essential clinical and pathophysiologic features of urinary tract malignancies, beginning with renal cell carcinoma (RCC) and followed by urothelial carcinoma of the bladder.We start with a patient ... Show More
29m 41s
Dec 2024
Kidney cancer - Take home messages for 2024
The UROONCO RCC editorial board chief editor Dr. Carmen Mir, and associate editors Dr. Teele Kuusk and Dr. Riccardo Bertolo share highlights of the important kidney cancer developments for 2024.  They summarise the results on several important trials such as FASTRACK, ZIRCON, KEY ... Show More
13m 51s
Dec 2024
Non-Muscle Invasive Bladder Cancer Basics with Dr. Kyle Richards
Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More
12m 52s